Preparation of a paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 6499-6515

  Chu, Kedan ^a   Chen, Lidian ^a   Xu, Wei ^a   Li, Huang ^a   Zhang, Yuqin ^a   Xie, Weirong ^a   Zheng, Jian ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Allergic rhinitis; In situ gel; Inclusion complex of paeonol and cyclodextrin; Nasal mucosal toxicity; Rheological studies; Thermodynamic study

Indexed keywords

BETA CYCLODEXTRIN; IMMUNOGLOBULIN E; LEUKOTRIENE E4; MACROGOL 6000; PEONOL; POLOXAMER; POLYMER;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RHEOLOGY; CHEMICAL COMPOSITION; CHINESE MEDICINE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; FEMALE; GUINEA PIG; HISTOPATHOLOGY; INFRARED SPECTROSCOPY; MALE; MOLECULAR WEIGHT; NONHUMAN; NOSE MUCOSA; TEMPERATURE SENSITIVITY; THERMODYNAMICS;

ANURA; CAVIA;

EID: 84875509508     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14036499     Document Type: Article

References (26)

1. Schenkel, E.J. Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis. Allergy Asthma Proc. 2006, 27, 465-472.
2. Lu, B. New Techniques and New Dosage Forms of Drugs, 1st ed.; People's Medical Publishing House: Beijing, China, 2002; p. 451.
3. Gizurason, S. The relevance of nasal physiology to the design of drug absorption studies. Adv. Drug Deliv. Rev. 1993, 11, 329-347.
4. Zhang, C.X.; Zhang, W.T.; Wang, D.K. The research progress of in situ gel, new type of drug delivery system. Chin. J. Hosp. Pharm. 2006, 26, 459-461.
5. Ning, L.L. Characteristics of ophthalmic in situ gel and issues in progress. Chin. J. New Drugs 2007, 16, 988-990.
6. Schmolka, I.R. Poloxamers in the pharmaceutical industry. In Polymers for Controlled Drug Delivery; Tarcha, P.J., Ed.; CRC Press: Boca Raton, FL, USA, 1991; pp. 189-214.
7. Chou, T.C. Anti-inflammatory and analgesic effects of paeonol in carrageenan evoked thermal hyperalgesia. Br. J. Pharmacol. 2003, 139, 1146-1152.
8. Ma, Y.L.; Bates, S.S.; Gurney, A.M. The effects of paeonol on the electrophysiological properties of cardiac ventricular myocytes. Eur. J. Pharmacol. 2006, 545, 87-92.
9. Kim, J.; Lee, H.; Lee, Y.; Oh, B.G.; Cho, C.; Kim, Y.; Shin, M.; Hong, M.; Jung, SK.; Bae, H. Inhibition effects of Moutan Cortex Radicis on secretion of eotaxin in A549 human epithelial cells and eosinophil migration. J. Ethnopharmacol. 2007, 114, 186-193.
10. Kim, S.H.; Kim, S.A.; Park, M.K., Kim, S.H.; Park, Y.D.; Na, H.J.; Kim, H.M.; Shin, M.K.; Ahn, K.S. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-a. Int. Immunopharmacol. 2004, 4, 279-287.
11. Tang, H.Y.; Yang, S.; Wang, J.B. Verview of preparation process, formulation reform and clinical application of paeonol. Jiangsu J. Trad. Chin. Med. 2004, 25, 58-60.
12. Hirlekar, R.; Kadam, V. Preformulation study of the inclusion complex irbesartan-β-cyelodextrin. AAPS PharmSciTech 2009, 10, 276-281.
13. Song, T.; Wang, D.K.; Gao, H.; Zhang, C.X.; Ji, B. Thermodynamic and rheological properties of therm osensitive gels for nasal delivery of ribavirin. Chin. J. Pharm. 2006, 37, 540-542.
14. De Santana, D.C.; Pupo, T.T.; Sauaia, M.G.; da Silva, R.S.; Lopez, R.F.V. Nitric oxide photorelease from hydrogels and from skin containing a nitro-ruthenium complex. Int. J. Pharm. 2010, 391, 21-28.
15. Jug, M.; BEeIREvIe-Lacan, M.; Bengez, S. Novel cyclodextrin-based film form ulation intended for buecal delivery of atenolol. Drug Dev. Ind. Pharm. 2009, 35, 796-807.
16. Xu, X.Y. The Identification of principal components of clathrate and complex with infrared spectral subtraction method. Chin. J. Pharm. Anal. 1997, 17, 87-89.
17. Lu, W.Y.; Chen, P.R.; Lin, G.Q. New stereoselective synthesis of thiamphenicol and florfenicol from enantiomerically pure cyanohydrin: A chemo-enzymatic approach. Tetrahedron 2008, 64, 7822-7827.
18. Schmolka, I.R. Artificialskin I. Preparation and properties and properties of pluronic F-127 gels for the treatment of burns. J. Biomed. Mater. Res. 1972, 6, 571-582.
19. Mao, S.; Shi, Z.; Bi, D. Research of nasal absorption of dipyrone solution. Chin. Pharm. J. 1997, 32, 87-90.
20. Song, C.J.; Wang, Y.; Wang, C.Y. Preparation and evaluation in vivo of scutellaria thermosensitive gel. China J. Chin. Mat. Med. 2008, 33, 628-631.
21. Miyazaki, S.; Nakamura, T.; Takada, M. Thermo-sensitive sol-gel transition of Pluronic F-127. Yakuzaigaku 1991, 51, 36-43.
22. Azade, T.; Fatemeh, A.; Rassoul, D. Temperature-responsive and biodegradable PVA: PVP k30: poloxamer 407 hydrogel for controlled delivery of human growth hormone (hGH). J. Pediatr. Endocr. Met. 2011, 24, 175-179.
23. Gratieri, T.; Gelfuso, G.M.; Rocha, E.M.; Sarmento, V.H.; de Freitas, O.; Lopez, R.F.V. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur. J. Pharm. Biopharm. 2010, 75, 186-193.
24. National Pharmacopoeia Committee. Chinese Pharmacopoeia, 1st ed.; TCM Science & Technology Publishing House: Beijing, China, 2010; pp. 268-269.
25. Jiang, X.G.; Cui, J.B.; Fang, X.L.; Wei, Y.; Xi, N.Z. Toxicity of drugs on nasal mucocilia and the method of its evaluation. Acta Pharm. Sin. 1995, 308, 848-853.
26. Zhang, Q.; Jiang, X.; Xiang, W.; Lu, W.; Su, L.; Shi, Z. Preparation of nimodipineloaded microemulsion for intranasal delivery and evaluation of the targeting efficiency to brain. Int. J. Pharm. 2004, 275, 85-96.